Skip to search formSkip to main contentSkip to account menu

HOE-498

Known as: HOE 498, HOE498 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Highly Cited
1986
Highly Cited
1986
The effects of the angiotensin converting enzyme (ACE) inhibitors captopril, enalapril, HOE 498, and its prodrug on reperfusion… 
Highly Cited
1986
Highly Cited
1986
Summary: The novel prodrug-converting-enzyme (CE) inhibitor perindopril (S9490-3) diacid was found to be as potent as ramipril… 
1986
1986
The spontaneously hypertensive rat (SHR) has many characteristics indicative of an overactive brain-angiotensin system. Since… 
Highly Cited
1985
Highly Cited
1985
Inhibition of angiotensin II generation in the plasma does not fully explain the antihypertensive effects of converting enzyme… 
1985
1985
Summary: The effect of various doses of the new angiotensin-converting enzyme inhibitor HOE 498 was compared with that of placebo… 
Highly Cited
1984
Highly Cited
1984
The mechanism of antihypertensive action of converting enzyme (CE) inhibitors was studied by comparing two compounds of different… 
1984
1984
After oral administration, 2 mg/kg in rat and dog, 10 mg in man, of the carbon-14-labeled angiotensin I converting enzyme… 
1984
1984
The convergent, diastereoselective synthesis of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3…